Latest Quarter
Q1 FY2026ended 2026-03-31 · filed 2026-04-28
$657.51M
$66.3M
$84.58M
$4.84
$16.86M
$1.54B
$847.99M
$91.2M
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, Chemed reported revenue of $657.5 million, up 1.6% year-over-year. Net income was $66.3 million, down 7.6% from the prior year, while operating income fell 10.7% to $84.6 million. Diluted EPS was $4.84, a decrease of 0.4% year-over-year. The company held $16.9 million in cash, $847.9 million in equity, and $91.2 million in long-term debt.
- •Revenue increased 1.6% YoY to $657.5 million.
- •Net income declined 7.6% YoY to $66.3 million.
- •Operating income fell 10.7% YoY to $84.6 million.
- •Diluted EPS was $4.84, down 0.4% YoY.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.